Vascular development in embryoid bodies: quantification of transgenic intervention and antiangiogenic treatment

scientific article

Vascular development in embryoid bodies: quantification of transgenic intervention and antiangiogenic treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10456-007-9076-Y
P698PubMed publication ID17577673

P50authorStephen K. SmithQ44253525
Cristin PrintQ41646647
P2093author name stringJeremy Skepper
D Stephen Charnock-Jones
James Bryant
Amanda Lisabeth Evans
P2860cites workEffects of mechanical forces on signal transduction and gene expression in endothelial cellsQ41695590
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cellsQ24616059
Establishment in culture of pluripotential cells from mouse embryosQ27860625
Derivation of completely cell culture-derived mice from early-passage embryonic stem cellsQ29547491
In vitro models of vasculogenesis and angiogenesisQ34220312
P433issue3
P921main subjectangiogenesis inhibitorQ574834
embryoid bodyQ3384920
P304page(s)217-226
P577publication date2007-06-19
P1433published inAngiogenesisQ15753544
P1476titleVascular development in embryoid bodies: quantification of transgenic intervention and antiangiogenic treatment
P478volume10

Reverse relations

cites work (P2860)
Q53253602Cyclic GMP protects endothelial progenitors from oxidative stress.
Q34992238Embryoid body formation from embryonic and induced pluripotent stem cells: Benefits of bioreactors
Q100633960Exposure to the natural alkaloid Berberine affects cardiovascular system morphogenesis and functionality during zebrafish development
Q28730832Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells
Q39000319Glycome and transcriptome regulation of vasculogenesis
Q33597282The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis

Search more.